466
Participants
Start Date
April 20, 2018
Primary Completion Date
December 2, 2018
Study Completion Date
January 31, 2020
Podofilox Gel 0.5%
Apply twice daily for three consecutive days, then discontinuing for four consecutive days, up to four treatment cycles
Condylox Topical Gel 0.5%
Apply twice daily for three consecutive days, then discontinuing for four consecutive days, up to four treatment cycles
Placebo Gel
Apply twice daily for three consecutive days, then discontinuing for four consecutive days, up to four treatment cycles
Paddington Testing Co, Inc, Philadelphia
Leon Medical Research, Miami
Well Pharma Medical Research Corp, Miami
TMC Life Research, Inc, Houston
"Ecology of Health LLC", Chelyabinsk
"State Budgetary Institution of Healthcare Chelyabinsk Regional Clinical Dermatovenerology Dispensary", Chelyabinsk
"State autonoumous institution of Healthcare of Moscow region Korolev Dermatovenerology dispensary", Korolyov
"Moscow scientific-practical center of Dermatovenerology and cosmetology", Moscow
"Clinic of urology №1 LLC", Penza
Rostov State Medical University, Rostov-on-Don
"State Budgetary Institution of Healthcare Dermatovenerologic dispensary #8 of Krasnogvardeyskiy district of Saint Petersburg", Saint Petersburg
"Regional State-Financed Health Institution of Healthcare Smolensk Dermatovenerologic dispensary", Smolensk
"Medical Center of Private Enterprise Dzerkalo", Dnipro
"Municipal institution Ivano-Frankivsk Regional Clinical Skin and Venereal Dispensary", Ivano-Frankivsk
"Municipal Health Care Institution Kharkiv City Clinical Dermatovenerologic Dispensary №5", Kharkiv
"Municipal Institution Rivne Regional Dermatology and Venerology Dispensary of Rivne Regional Council", Rivne
"Municipal Institution Zaporizhzhya Regional Dermatovenerology Clinical Dispensary of Zaporizhzhya Regional Council", Zaporizhzhya
bioRASI, LLC
INDUSTRY
Dermax SA
INDUSTRY